SARASOTA, Fla., Jan. 9, 2018 /PRNewswire/ -- Lilac Corp is happy to announce the launch of Nolopecia, a new herbal treatment for hair loss and balding. Lilac Corp is the company that sells the highly acclaimed Gene-Eden-VIR and Novirin.
Dr. Hanan Polansky and his team from the Center for the Biology of Chronic Disease discovered that latent viruses increase the production of the two proteins associated with the development of hair loss and balding in both men and women, dihydrotestosterone (DHT) and the androgen receptor (AR). Following this discovery, Lilac Corp developed Nolopecia, a natural treatment that targets the latent viruses that modify the levels of DHT and AR. Controlling the number of latent viruses helps maintain normal levels of these two proteins, resulting in normal hair growth.
Nolopecia comes in a form of a capsule taken twice a day orally. This product is unique. It is the only product on the market that targets latent viruses, which according to Dr. Hanan Polansky, cause most cases of hair loss and balding (androgenic alopecia). Lilac Corp is pleased to invite interested individuals to try this revolutionary product. Nolopecia can be ordered on the product website at http://nolopecia.com/
SOURCE Lilac Corp